Search clinical trials for: intermediate and high risk cancer of the prostate
Total 492019 results
-
British Columbia Cancer AgencyUniversity of British Columbia; Vancouver Prostate Centre; BC Cancer FoundationRecruitingLocalized Prostate CarcinomaCanada
-
Ottawa Hospital Research InstituteKnight Therapeutics (USA) IncRecruiting
-
Genesis Research LLCRecruitingProstate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance RegimenUnited States
-
University of NebraskaRecruitingProstatic CancerUnited States
-
Washington University School of MedicineVarian Medical SystemsRecruitingProstate Cancer | Cancer of the ProstateUnited States
-
National Cancer Institute (NCI)Recruiting
-
NRG OncologyNational Cancer Institute (NCI)Recruiting
-
Marco Lorenzo BonuAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaRecruiting
-
Daniel George, MDMerck Sharp & Dohme LLCNot yet recruiting
-
University of VirginiaRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI)Recruiting
-
British Columbia Cancer AgencyBC Cancer FoundationRecruiting
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingProstate Cancer | Prostatic AdenocarcinomaUnited States
-
Hospices Civils de LyonActive, not recruiting
-
Mayo ClinicActive, not recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Astellas Pharma Inc; Medivation, Inc.Active, not recruitingRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Lawson Health Research InstituteAbbVie; Canadian Association of Radiation OncologyActive, not recruiting
-
British Columbia Cancer AgencyActive, not recruitingProstate CancerCanada
-
IsoRay Medical, Inc.Swedish Medical CenterWithdrawn
-
Jonsson Comprehensive Cancer CenterWithdrawnProstate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States
-
Singapore General HospitalCompletedCancer of the ProstateSingapore
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnProstate Cancer Stage I AJCC V6 | Prostate Cancer Stage II | Prostate Cancer Stage IIIUnited States
-
Cambridge University Hospitals NHS Foundation TrustAstraZenecaCompleted
-
Sunnybrook Health Sciences CentreUnknownCarcinoma of the ProstateCanada
-
NYU Langone HealthRecruitingProstate CancerUnited States
-
University Hospital, EssenBristol-Myers Squibb; Advanced Accelerator ApplicationsNot yet recruitingVery High Risk Prostate CarcinomaGermany
-
Region SkaneRecruiting
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
University of OklahomaNot yet recruitingAndrogen Deprivation Therapy | Locally Advanced Prostate CancerUnited States
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
NHS LothianNot yet recruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate Cancer
-
Yale UniversityPfizerRecruiting
-
Clarity Pharmaceuticals LtdRecruitingProstatic Neoplasms | Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
FutureChemRecruitingHigh Risk Prostate CarcinomaKorea, Republic of
-
Comprehensive Cancer Centre The NetherlandsRecruitingProstate Cancer | Prostate AdenocarcinomaNetherlands
-
Turku University HospitalRecruitingProstate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate CancerFinland
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, United States, Australia, Brazil, France, Germany, Taiwan, Denmark, China, Netherlands, Portugal, Japan, Canada, Finland, Italy, Hungary, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Xian-Janssen Pharmaceutical Ltd.Not yet recruitingProstate Cancer | Biochemical Recurrence | High RiskChina
-
University of ChicagoRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
West German Study GroupAstraZenecaNot yet recruitingHER2-positive Early Breast CancerGermany
-
Francis Medical Inc.RecruitingProstate CancerUnited States
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
Regina Elena Cancer InstituteRecruitingProstate CancerItaly
-
Assistance Publique - Hôpitaux de ParisRecruitingHigh-risk Prostate CancerFrance